2019
DOI: 10.1016/j.bioorg.2018.10.031
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, in vitro urease inhibition and molecular docking studies of some novel quinazolin-4(3H)-one derivatives containing triazole, thiadiazole and thiosemicarbazide functionalities

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
31
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8

Relationship

4
4

Authors

Journals

citations
Cited by 40 publications
(32 citation statements)
references
References 43 publications
1
31
0
Order By: Relevance
“…[16,17] Many nitrogen atom containing azolic templates have recently been reported as antiurease agents as well. Norfloxacin hybrids, [18] conazole analogue, [19] benzimidazole derivatives, [20] thiazole derivative, [21] azol-β-lactam, [22] benzisoelenazolone, [23] urea-triazole conjugate, [24] thiadiazole derivative [25] are some of the crucial examples ( Figure 1).…”
Section: Introductionmentioning
confidence: 99%
“…[16,17] Many nitrogen atom containing azolic templates have recently been reported as antiurease agents as well. Norfloxacin hybrids, [18] conazole analogue, [19] benzimidazole derivatives, [20] thiazole derivative, [21] azol-β-lactam, [22] benzisoelenazolone, [23] urea-triazole conjugate, [24] thiadiazole derivative [25] are some of the crucial examples ( Figure 1).…”
Section: Introductionmentioning
confidence: 99%
“…For residues within 5 Å of the ligand, Prime refinement was used. Glide redocking was carried out for structures within 30 kcal/mol of the best poses (Menteşe et al, 2019;€ Ozil et al, 2020). The binding affinity was determined and ranked based on the docking score.…”
Section: The Protocol Of Docking Studymentioning
confidence: 99%
“…Although different candidates are in various phases of discovery and development pipeline [17][18][19][20], no drugs with novel skeleton against H. pylori have been approved recently. Compound 1c with unique skeleton exhibited most the promising potency against H. pylori compared with PMT, and was selected as the representative compound for further investigation.…”
Section: Pharmacological Evaluationmentioning
confidence: 99%
“…H. pylori creates a local neutral environment for survival by continuously releasing ammonia into succus gastricus, mediated by its own urease. Therefore, urease plays an essential role for H. pylori colonization in the human stomach, and is considered to be a critical target in the exploitation of anti-H. pylori agents [17][18][19][20]. Until now, no drug has been approved by Food and Drug Administration (FDA) targeting H. pylori urease [20,21].…”
Section: Introductionmentioning
confidence: 99%